3137 results for «880»
3137 results
Procedural planning and risk stratification in multivessel PCI
22 May 2025 – From EuroPCR 2025
This session focuses on procedural planning and risk stratification in multivessel PCI, presenting data from the TALENT and FIRE trials, prognostic value of post-PCI physiological assessments, and an innovative study comparing large language models in managing complex interventional cardiology cases.
TAVI outcomes
22 May 2025 – From EuroPCR 2025
Examine contemporary outcomes of transcatheter aortic valve implantation (TAVI) across diverse patient populations and device generations. This session presents data on severe aortic stenosis stratified by resting gradient, comparisons between bicuspid and tricuspid valve stenosis, and clinical results of intra-annular versus supra-annular devices, including two-year outcomes...
What did we learn from my TAVI complications?
22 May 2025 – From EuroPCR 2025
Review critical lessons from TAVI complications, focusing on early identification and management of access site issues and acute coronary obstruction. Learn effective preventive actions and procedural strategies to minimize severe TAVI-related complications through detailed case discussions.
Coronary physiology: FFR and beyond
22 May 2025 – From EuroPCR 2025
Advance your understanding of coronary physiology with a focus on fractional flow reserve (FFR) and beyond. This session covers randomized trials comparing physiology-guided treatment to standard care in ANOCA, graft patency related to quantitative flow ratio, impacts of microvascular dysfunction on patient outcomes, and prognostic value...
All you need to know on aorto iliac disease during TAVI: from access to complications management
22 May 2025 – From EuroPCR 2025
Gain expertise in managing aorto-iliac disease during TAVI procedures, from access planning to complication management. This session covers key imaging techniques, decision-making regarding stenting and lesion modification, approaches to access-related complications, and criteria for involving vascular surgeons, ensuring procedural safety and success.
Clinical and technical factors for decision-making in treatment of left main coronary artery disease
22 May 2025 – From EuroPCR 2025
Delve into decision-making factors in treating left main coronary artery disease, particularly in challenging scenarios. This session discusses the application of new SOLACI guidelines, critical strategy reflections, and real-world cases illustrating optimal left main PCI approaches.
TAVI in bicuspid aortic valve disease
22 May 2025 – From EuroPCR 2025
Explore the unique challenges of TAVI in bicuspid aortic valve disease with a focus on long-term outcomes, residual gradients, prosthesis-patient mismatch, and anatomical subtype comparisons. This session draws on international registry data to inform clinical decision-making and optimize procedural strategies in this complex patient population.
Advanced tools for the diagnosis of coronary artery disease
22 May 2025 – From EuroPCR 2025
This session highlights advanced diagnostic tools for coronary artery disease, focusing on innovative pressure gradient assessments, computed tomography perfusion accuracy in stented patients, head-to-head comparisons of IQ-FFR with invasive FFR, and comprehensive evaluations of coronary physiology and plaque vulnerability derived from angiography.
Optimising TEER in challenging anatomies
22 May 2025 – From EuroPCR 2025
Optimize transcatheter edge-to-edge repair (TEER) strategies in challenging anatomies with focus on tricuspid valve interventions, recognition of multivalvular disease, and planning combined mitral and tricuspid TEER procedures. Case studies highlight feasibility challenges and dual valve repair approaches.
Redefining the red flags: early detection of myocardial infarction in women
22 May 2025 – From EuroPCR 2025
Gain a unique patient-centered perspective on early myocardial infarction detection in women. This session features a survivor's story, collaborative step-by-step clinical approaches, and key aspects of cardiac rehabilitation, emphasizing shared decision-making to improve patient outcomes in complex cases.
Advancing knowledge and innovations in peripheral interventions
22 May 2025 – From EuroPCR 2025
Expand your expertise in peripheral interventions with a focus on recent innovations and clinical insights. This session covers pre-clinical results of a novel Hybrid Drug-Eluting Stent for below-the-knee arteries, the prognostic impact of proteinuria in LEAD patients with chronic kidney disease, beta-blocker therapy effects post-frozen elephant...
Optimised patient selection for carotid artery stenting
22 May 2025 – From EuroPCR 2025
Optimize patient selection for carotid artery stenting with this session that highlights personalized approaches to ischaemic stroke treatment. Review bioactive stents versus endovascular therapy, feasibility and outcomes in near-occlusion cases, and long-term retrospective analyses supporting carotid stenting as a strategic ally in embolic stroke management.
LAA closure in challenging scenarios
22 May 2025 – From EuroPCR 2025
This session addresses the complexities of left atrial appendage (LAA) closure in challenging anatomical and clinical scenarios. Learn from compelling cases including management of incomplete surgical LAA ligation, closure of large and complex peridevice leaks, and navigating difficult anatomy in elderly patients. Emphasizing innovative techniques and...
Contemporary outcomes of PCI patients
22 May 2025 – From EuroPCR 2025
Examine contemporary outcomes in PCI patients through a collection of studies addressing angiographic complication incidences, safety of same-day discharge post-complex PCI, age-related outcome impacts in TAVI patients, and comparative long-term antiplatelet strategies. The session also explores timing effects in routine versus off-hours PCI.
Updates on percutaneous treatment of pulmonary embolism
22 May 2025 – From EuroPCR 2025
Stay abreast of the latest advances in percutaneous treatment of pulmonary embolism. This session covers clinical outcomes with novel vacuum thrombectomy devices, mechanical thrombectomy registries, catheter-directed therapies in intermediate-high risk PE, and profiles of subacute PE interventions to inform optimal treatment strategies.
Anatomy, physiology and clinical judgment: insights from contemporary strategies to guide PCI
22 May 2025 – From EuroPCR 2025
Discover contemporary strategies integrating anatomy, physiology, and clinical judgment to guide percutaneous coronary intervention (PCI). This session explores the impact of stress cardiovascular magnetic resonance in primary prevention, viability-guided PCI, and physiology-based decision-making including quantitative flow ratio (QFR). Learn about identifying patients at risk for major...
Percutaneous aortic interventions: mastering the complexity
22 May 2025 – From EuroPCR 2025
Master complex percutaneous aortic interventions in this detailed session. Topics include managing life-threatening complications, percutaneous repair of ascending aortic graft pseudoaneurysms, aortic stenting for total occlusions, and troubleshooting endovascular aortic repair failures, providing a comprehensive overview of challenging aortic cases.
DCB in STEMI : why, when and how ?
22 May 2025 – From EuroPCR 2025
Explore the evolving role of drug-coated balloons (DCB) in the management of STEMI patients. This session covers practical approaches including primary PCI with DEB, unconventional solutions in urgent scenarios, and personalized treatment strategies especially in very young patients. Learn how DCB technology intersects with complex lesion...
Novel tools and techniques to manage complex PCI scenarios
22 May 2025 – From EuroPCR 2025
This session introduces novel tools and techniques to manage complex PCI scenarios. Key topics include intravascular lithotripsy advancements for in-stent restenosis, innovative balloon-assisted fenestration of covered stents, long-term outcomes of drug-eluting balloons post directional coronary atherectomy, and safety and efficacy data on a novel high-pressure cutting...
When angina cannot be cured with stents: what are the remaining options
22 May 2025 – From EuroPCR 2025
Explore therapeutic options for patients with angina refractory to stenting. This session reviews the efficacy and clinical outcomes of coronary sinus (CS) reducer implantation for microvascular dysfunction, factors influencing procedural success, next-generation CS reducer innovations, and the role of aspirin in angina without obstructive coronary disease.
